ArticleJCO precision oncology2022

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.

Hiroko Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.